Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?

Background: Despite an existing safe and effective vaccine for hepatitis B virus (HBV), it is still a major public health concern. Nowadays, several drugs are used to treat chronic hepatitis B; however, full healing remains controversial. The viral covalently closed circular DNA (cccDNA) formed by H...

Full description

Saved in:

Bibliographic Details
Main Authors:	Giovana Paula Angelice, Pedro Henrique Roque, Gabriel Valente, Krishna Galvão, Livia Melo Villar, Vinicius Motta Mello, Francisco C. A. Mello, Bárbara Vieira Lago
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Series:	Viruses
Subjects:	hepatitis B virus (HBV) chronic hepatitis RNA interference (RNAi) gene therapy covalently closed circular DNA (cccDNA)
Online Access:	https://www.mdpi.com/1999-4915/16/11/1710
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products
by: Liyuan Hao, et al.
Published: (2025-06-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
by: Wei He, et al.
Published: (2024-12-01)

Lamin A/C promotes HBV transcription by modulating histone modification associated with cccDNA minichromosome in an HBx-dependent manner
by: Linshan Jiang, et al.
Published: (2025-06-01)

CRISPR/Cas9 for hepatitis B virus infection treatment
by: Bo Cai, et al.
Published: (2023-05-01)

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy
by: Kongying Hu, et al.
Published: (2024-12-01)

Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
by: Deok-Hwa Seo, et al.
Published: (2024-12-01)

The feasibility of establishing a hamster model for HBV infection: in vitro evidence
by: Hu Zhang, et al.
Published: (2024-11-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication
by: André Boonstra, et al.
Published: (2025-01-01)

Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
by: Dong Li, et al.
Published: (2024-08-01)

Cracking the code of HBV persistence: cutting-edge approaches to targeting cccDNA in chronic hepatitis B with or without pyogenic liver Abscesses
by: Umar Saeed, et al.
Published: (2025-03-01)

Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01)

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication
by: Caiyue Ren, et al.
Published: (2024-12-01)

SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential
by: Johannes Bächer, et al.
Published: (2024-10-01)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
by: Shao-Juan Wang, et al.
Published: (2021-01-01)

Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11
by: Congle Shen, et al.
Published: (2020-01-01)

Comparison of HBV-DNA Levels with Biochemical and Microbiological Parameters for Chronic Hepatitis Evaluation, Bursa, Turkey
by: Sanem Karadag Gecgel
Published: (2021-03-01)

Analysis of HBV infection characteristics and OBI prevalence in pregnant women: a focus on HBcAb + alone or in combination with HBeAb + subgroups in Northwest China
by: Yun Xie, et al.
Published: (2025-08-01)

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
by: Patricia Gita Naully, et al.
Published: (2025-01-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
by: I. A. Gabdrakhmanov, et al.
Published: (2016-02-01)

Occult hepatitis B in Egyptian thalassemic children
by: Olfat Shaker, et al.
Published: (2011-07-01)

Association between Hepatitis B virus infection and COVID-19: outcomes from clinical analysis and online survey from Beijing, China
by: Fei Lin, et al.
Published: (2024-12-01)

Correlation between virological response and portal vein thrombosis in patients with chronic hepatitis B
by: Zhanghao Li, et al.
Published: (2025-07-01)

Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings
by: Simmone D’souza, et al.
Published: (2025-03-01)

Sirtuin 2 inhibitor AGK2 exerts antiviral effects by inducing epigenetic suppression of hepatitis B virus covalently closed circular DNA through recruitment of repressive histone lysine methyltransferases and reduction of cccDNA
by: Jumi Kim, et al.
Published: (2025-04-01)

Ministring DNA (msDNA): a novel linear covalently-closed DNA with enhanced stability for gene and cell therapy applications
by: Wai Kuen Hung, et al.
Published: (2025-05-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Effects of cellular membranes and the precore protein on hepatitis B virus core particle assembly and DNA replication
by: Yu-Chen Chuang, et al.
Published: (2025-04-01)

Immunogenicity and protective efficacy of DHBV DNA vaccines expressing envelope and capsid fusion proteins in ducks delivered by attenuated Salmonella typhimurium
by: Si-yang LIU, et al.
Published: (2018-04-01)

Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
by: Michela di Fonzo, et al.
Published: (2010-02-01)

Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
by: Alfredo Marzano, et al.
Published: (2010-12-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

48-week prognostic analysis of very low-level viremia in patients with hepatitis B cirrhosis: a single-center retrospective study
by: Yinong Feng, et al.
Published: (2025-07-01)

Presentación dosier: El trabajo de las maestras y la educación femenina en Argentina, Chile y Uruguay (1860-1960)
by: Laura Graciela Rodríguez, et al.
Published: (2024-12-01)

PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
by: Anil Pathare, et al.
Published: (2019-10-01)

Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system
by: Yiqing Sun, et al.
Published: (2025-05-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)